Page 45 - Central Drug Authority Annual Report 2021
P. 45
DEPARTMENT KEY ACTIVITY KEY ACTIVITY ACHIEVEMENTS MTSF CONFERENCE
DELIVERABLE CONTRIBUTION OUT- RESOLUTION
TO OUTCOME COMES NUMBER
1DWLRQDO Enhance operational Engage and 6HFXULW\ $FWLYLWLHV &ROODERUDWHG ZLWK 6$36
Prosecuting coordination at all collaborate with All including Directorate for
Authority OHYHOV other departments Priority Crime
and stakeholders ,QYHVWLJDWLRQV '3&,
1DWLRQDO 0LWLJDWH WKH VXSSO\ RI Increase successful 6HFXULW\ $FWLYLWLHV &DVHV 4
Prosecuting drugs and liquor SURVHFXWLRQV All
Authority through enhanced &RQYLFWLRQV DQG
operations 6HQWHQFHV
LQYHVWLJDWLRQV DQG 6XFFHVVIXO 'LYHUVLRQV
SURVHFXWLRQV
1DWLRQDO Enhance operational 5HPRYH SURˉW IURP 6HFXULW\ $FWLYLWLHV &RXUW 2UGHUV 4
Prosecuting coordination at all FULPLQDO DFWLYLW\ Reduction in REWDLQHG
Authority OHYHOV corruption and 5 0LOOLRQ UHFRYHUHG
PRQH\ ODXQGHULQJ
6$36 7KH DQDO\VLV DQG $QDO\VH DOO DYDLODEOH 6RFLDO $FWLYLW\ WKUHDWV 4
SURYLVLRQ RI information and Respond to LGHQWLˉHG
intelligence products intelligence to HPHUJLQJ WUHQGV
to enhance the identify the crime
intelligence picture
DQG HIIHFWLYHQHVV RI threat and risks
law enforcement impacting on the
RSHUDWLRQV safety and security
of the country and
LWV LQKDELWDQWV
6$36 7KH DQDO\VLV DQG $QDO\VH DOO DYDLODEOH 6RFLDO $FWLYLW\ WKUHDW DQG ULVN 4
SURYLVLRQ RI information and Respond to SURˉOH DVVHVVPHQWV
intelligence products intelligence on a HPHUJLQJ WUHQGV JHQHUDWHG
to enhance the suspect/person of
intelligence picture interest to generate
DQG HIIHFWLYHQHVV RI SURˉOHV IRU UHDFWLYH
law enforcement 6$36 RSHUDWLRQV
RSHUDWLRQV
6$36 7KH DQDO\VLV DQG $QDO\VH DOO DYDLODEOH 6HFXULW\ $FWLYLW\ SURˉOHV
SURYLVLRQ RI Information and Reduction of generated for
intelligence products intelligence on a power and reach UHDFWLYH 6$36
to enhance the suspect/person of RI RUJDQL]HG RSHUDWLRQV
intelligence picture interest to generate FULPH
DQG HIIHFWLYHQHVV RI SURˉOHV IRU UHDFWLYH
law enforcement 6$36 RSHUDWLRQV
RSHUDWLRQV
Annual Report 2020/2021 Central Drug Authority 43